The results of the trial into a new type of smart drug given to Acute Myeloid Leukaemia patients show that GO treatment could improve the effectiveness of chemotherapy without excessively increasing side effects, according to the study.
The study, published in the Journal of Clinical Oncology, said that this may provide a potential lifeline for older AML patients who are often too frail to tolerate more intensive chemotherapy regimes.
More top news
Tory divisions over a controversial benefit reform could be exposed in a Labour vote in the House of Commons on Wednesday.
Should no deal be negotiated, Dover, the UK's gateway to Europe, would be one of the places to feel the effects of this most.
The Young Vic’s new artistic director Kwame Kwei-Armah has said he could back quotas to help improve the diversity of British theatre.